HMMR and acute myeloid leukemia: HMMR-specific TCR-T cells demonstrated high efficacy in killing AML in vitro and in vivo, and treating mice with HMMR-specific TCR-T combined with interleukin (IL)-15 exhibited potent efficiency in eliminating tumors and prolonged survival of AML-bearing mice (46).